DK1493441T3 - Terapeutisk middel for næringskompentenceforstyrrelse i maven - Google Patents
Terapeutisk middel for næringskompentenceforstyrrelse i mavenInfo
- Publication number
- DK1493441T3 DK1493441T3 DK03745958.3T DK03745958T DK1493441T3 DK 1493441 T3 DK1493441 T3 DK 1493441T3 DK 03745958 T DK03745958 T DK 03745958T DK 1493441 T3 DK1493441 T3 DK 1493441T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- therapeutic agent
- stomach
- disorder
- competence
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title 1
- 210000002784 stomach Anatomy 0.000 title 1
- 230000004308 accommodation Effects 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001771 impaired effect Effects 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002104894 | 2002-04-08 | ||
| PCT/JP2003/004445 WO2003084537A1 (en) | 2002-04-08 | 2003-04-08 | Therapeutic agent for food competence disorder in stomach |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1493441T3 true DK1493441T3 (da) | 2011-10-17 |
Family
ID=28786350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03745958.3T DK1493441T3 (da) | 2002-04-08 | 2003-04-08 | Terapeutisk middel for næringskompentenceforstyrrelse i maven |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20050176788A1 (enExample) |
| EP (2) | EP2301540A1 (enExample) |
| JP (2) | JP5281226B2 (enExample) |
| KR (4) | KR20110010837A (enExample) |
| CN (2) | CN1646123A (enExample) |
| AT (1) | ATE522214T1 (enExample) |
| AU (1) | AU2003236326B2 (enExample) |
| CA (1) | CA2481916C (enExample) |
| CY (1) | CY1112057T1 (enExample) |
| DK (1) | DK1493441T3 (enExample) |
| ES (1) | ES2368732T3 (enExample) |
| PT (1) | PT1493441E (enExample) |
| SI (1) | SI1493441T1 (enExample) |
| WO (1) | WO2003084537A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104447612A (zh) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 阿考替胺水合物晶型及其制备方法和用途 |
| CN103980226A (zh) * | 2014-05-10 | 2014-08-13 | 杭州新博思生物医药有限公司 | 盐酸阿考替胺水合物晶型及其制备方法 |
| CN105315225A (zh) * | 2014-07-07 | 2016-02-10 | 中美华世通生物医药科技（武汉）有限公司 | 阿考替胺的酸加成盐及其制备方法 |
| CN104045606B (zh) * | 2014-07-11 | 2015-09-30 | 杭州新博思生物医药有限公司 | 一锅法制备阿考替胺盐酸盐的方法 |
| CN109988121B (zh) * | 2019-04-28 | 2023-01-03 | 梯尔希（南京）药物研发有限公司 | 一种阿考替胺衍生物的制备方法 |
| MX2024000751A (es) | 2021-07-14 | 2024-03-25 | Blueprint Medicines Corp | Compuestos heterociclicos como inhibidores de map4k1. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1063442C (zh) * | 1995-05-18 | 2001-03-21 | 泽里新药工业株式会社 | 氨基噻唑衍生物、含有它们的药物组合物及其用途 |
| JPH10212271A (ja) | 1997-01-31 | 1998-08-11 | Zeria Pharmaceut Co Ltd | Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体 |
| DK0994108T3 (da) * | 1997-06-24 | 2003-08-18 | Zeria Pharm Co Ltd | Fremgangsmåde til fremstilling af 2-hydroxybenzamidderivater |
| US5981556A (en) * | 1997-07-22 | 1999-11-09 | G.D. Searle & Co. | 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors |
| CA2352278A1 (en) * | 1998-11-23 | 2000-06-02 | Janssen Pharmaceutica, N.V. | Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia |
| UA73122C2 (en) * | 1999-06-02 | 2005-06-15 | Janssen Pharmaceutica Nv | Derivatives of benzodioxane, benzofuran or benzopyran substituted by aminoalkyl |
| AU782648B2 (en) * | 1999-11-23 | 2005-08-18 | Janssen Pharmaceutica N.V. | Use of 5HT3 agonists for relaxing the fundus |
| GB0002336D0 (en) * | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
| JP4876367B2 (ja) * | 2000-09-08 | 2012-02-15 | ゼリア新薬工業株式会社 | アミノチアゾール誘導体を有効成分とする大腸運動不全治療剤 |
| US6986882B2 (en) * | 2002-01-17 | 2006-01-17 | Astrazeneca Ab | Therapy for functional dyspepsia |
-
2003
- 2003-04-08 EP EP10010621A patent/EP2301540A1/en not_active Withdrawn
- 2003-04-08 KR KR1020117000220A patent/KR20110010837A/ko not_active Ceased
- 2003-04-08 AU AU2003236326A patent/AU2003236326B2/en not_active Expired
- 2003-04-08 CN CNA038079755A patent/CN1646123A/zh active Pending
- 2003-04-08 ES ES03745958T patent/ES2368732T3/es not_active Expired - Lifetime
- 2003-04-08 AT AT03745958T patent/ATE522214T1/de active
- 2003-04-08 DK DK03745958.3T patent/DK1493441T3/da active
- 2003-04-08 WO PCT/JP2003/004445 patent/WO2003084537A1/ja not_active Ceased
- 2003-04-08 PT PT03745958T patent/PT1493441E/pt unknown
- 2003-04-08 CN CN201010611741.5A patent/CN102125551B/zh not_active Expired - Lifetime
- 2003-04-08 CA CA2481916A patent/CA2481916C/en not_active Expired - Lifetime
- 2003-04-08 US US10/509,335 patent/US20050176788A1/en not_active Abandoned
- 2003-04-08 SI SI200332073T patent/SI1493441T1/sl unknown
- 2003-04-08 KR KR10-2004-7015764A patent/KR20050002925A/ko not_active Ceased
- 2003-04-08 KR KR1020127005319A patent/KR20120037035A/ko not_active Ceased
- 2003-04-08 EP EP03745958A patent/EP1493441B1/en not_active Expired - Lifetime
- 2003-04-08 KR KR1020137022604A patent/KR101423284B1/ko not_active Expired - Lifetime
- 2003-04-08 JP JP2003581777A patent/JP5281226B2/ja not_active Expired - Lifetime
-
2009
- 2009-02-17 US US12/372,234 patent/US20090156652A1/en not_active Abandoned
-
2011
- 2011-01-05 JP JP2011000499A patent/JP5360075B2/ja not_active Expired - Lifetime
- 2011-11-16 CY CY20111101103T patent/CY1112057T1/el unknown
-
2014
- 2014-12-22 US US14/579,102 patent/US20150141475A1/en not_active Abandoned
-
2020
- 2020-08-20 US US16/998,637 patent/US20200375954A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE522214T1 (de) | 2011-09-15 |
| KR101423284B1 (ko) | 2014-07-24 |
| CN1646123A (zh) | 2005-07-27 |
| US20200375954A1 (en) | 2020-12-03 |
| JPWO2003084537A1 (ja) | 2005-08-11 |
| AU2003236326A1 (en) | 2003-10-20 |
| EP1493441A1 (en) | 2005-01-05 |
| EP1493441A4 (en) | 2007-10-17 |
| US20090156652A1 (en) | 2009-06-18 |
| KR20110010837A (ko) | 2011-02-07 |
| JP5360075B2 (ja) | 2013-12-04 |
| CA2481916A1 (en) | 2003-10-16 |
| US20050176788A1 (en) | 2005-08-11 |
| US20150141475A1 (en) | 2015-05-21 |
| JP5281226B2 (ja) | 2013-09-04 |
| CA2481916C (en) | 2013-02-26 |
| JP2011068692A (ja) | 2011-04-07 |
| SI1493441T1 (sl) | 2011-12-30 |
| KR20130101162A (ko) | 2013-09-12 |
| CY1112057T1 (el) | 2015-11-04 |
| PT1493441E (pt) | 2011-09-28 |
| ES2368732T3 (es) | 2011-11-21 |
| AU2003236326B2 (en) | 2008-02-28 |
| KR20050002925A (ko) | 2005-01-10 |
| WO2003084537A1 (en) | 2003-10-16 |
| CN102125551A (zh) | 2011-07-20 |
| KR20120037035A (ko) | 2012-04-18 |
| EP2301540A1 (en) | 2011-03-30 |
| EP1493441B1 (en) | 2011-08-31 |
| CN102125551B (zh) | 2015-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1698624A4 (en) | phenylpropanoic acid derivatives | |
| EP1679309A4 (en) | ANTISTRESS MEDICAMENT AND ITS MEDICAL USE | |
| DK1740584T5 (da) | Kondenseret chinolinderivat og anvendelse deraf | |
| DK1602660T3 (da) | Aminophosphonsyrederivater, additionssalte deraf og S1P-receptormodulatorer | |
| EA201070202A1 (ru) | Производное оксопиразина и гербицид | |
| BR112012026948A2 (pt) | composto, composição farmacêutica, e, métodos para melhorar o metabolismo ósseo, para previnir ou tratar uma doença associada com metabolismo ósseo e para previnir ou tratar osteoporose. | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| NO20020968L (no) | Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav | |
| MX2009010024A (es) | Nuevo compuesto de adenina. | |
| RU2011113967A (ru) | Новое производное простагландина i2 | |
| DE69935718D1 (de) | Antidiabetische medikamente | |
| BRPI0517232A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, ativador da glicocinase, e, agentes terapêuticos e/ou profiláticos para diabetes e para obesidade | |
| EP1775289A4 (en) | NEW IMIDAZOLIDINE DERIVATIVES | |
| DK1961734T3 (da) | Aminforbindelse og anvendelse deraf til medicinske formål | |
| CO5550494A2 (es) | Derivados de diamina, proceso para producir los derivados de diamina, y fungicidas que contienen los derivados de diamina como ingrediente activo | |
| SI1493441T1 (sl) | Terapevtsko sredstvo za motnjo prilagoditve Ĺľelodca na zauĹľito prehrano | |
| SI1970372T1 (sl) | Soli 9-oksoakridin-10-ocetne kisline z 1-alkilamino-1-deoksi-polioli | |
| ATE525386T1 (de) | 3'-ethynylcytidinderivat | |
| TR200102082T2 (tr) | Spesifikasyon benzamit türevi ve bunu içeren ilaç | |
| TW200505892A (en) | Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use | |
| NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
| EP1589023A4 (en) | oligosaccharide | |
| WO2008059068A3 (de) | Carbonyl-substituierte titanocene | |
| MX2008002753A (es) | Derivados de piridazinona utilizados para el tratamiento de dolor. |